Delivery Order 75D30123D16461-75D30123F00001
Award Date
8/15/23
Potential Completion Date
8/14/28
Potential Value
$2.8M
Federal Agency
CDC Pittsburgh
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
R799 - Support- Management: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,725,034.17 firm-fixed-price definitive contract to Glaxosmithkline, LLC for vaccine storage and rotation services. The contract has an ultimate completion date of August 14, 2023 and was awarded on August 15, 2018. The contract does not have a set-aside designation. Glaxosmithkline, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies, will perform the work...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...
This federal contract award, with a total ceiling value of $62,952.00, was issued by the Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC for the procurement of services for storage and stability of vaccine bulk lots from prior contracts for the U.S. Department of Defense (DoD). The award is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract 75A50122D00002, during the base period year 2. The contract is a firm fixed-price...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,085,922,457.04 firm fixed price contract to Glaxosmithkline, LLC for the provision of vaccines for children. The contract, which did not have a set-aside designation, has a performance period ending on March 31, 2018. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of vaccines, antivirals, and other pharmaceutical products to federal agencies including the...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC on December 23, 2016 for the 2017 adult flu season. The firm fixed price contract has a ceiling value of $12,408,000.00 and a performance period ending February 28, 2018. The contract does not have a set-aside designation. GlaxoSmithKline, a pharmaceutical company, has provided a range of products to U.S. government agencies through federal contracts, including influenza...
This federal contract award to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company, is for the supply of GSK Travel Vaccines. The contract is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price (FFP) pricing type, valued at $117,000.00, and has an ultimate completion date of December 31, 2025. The award was made on February 27, 2025 by the Department of Justice, Headquarters Division, a civilian federal agency. Glaxosmithkline, LLC has been awarded multiple...
This is a modification to a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The original contract had a ceiling value of $6,999,971.04 and was awarded on a firm fixed price basis with no set-aside designation. The contract is for the delivery of pharmaceutical goods and services, including influenza...
This is a $50,556,695.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, titled "2016 VFA - GSK", is for a firm fixed price and has an ultimate completion date of June 30, 2017. It is not a set-aside contract. Glaxosmithkline has provided a range of pharmaceutical goods and...
This is a $144,059.82 firm fixed price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC, a foreign-owned for-profit pharmaceutical company, to provide vaccines and other pharmaceutical products. The contract is issued under the General Services Administration's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The delivery order supports disease prevention efforts, immunization programs, and healthcare services, with performance in...
This is a federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of influenza vaccines. The contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a potential value of $1,319,230.00. There was no set-aside designation used for this award. GlaxoSmithKline has provided a...